EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Comparison of the effectiveness of pirfenidone with corticosteroids in post-COVID fibrosis – A quasi experimental study

Muhammad Rafay Rasheed, Kulsoom Farhat, Shabana Ali, Ikramullah Khan, Rizwan Abdul Malik

Journal of the Pakistan Medical Association · 2026-11-01 · 76 (11) · 1824-1827

DOI: 10.47391/jpma.23212 ↗
AbstractBibliografische Angaben

Abstract

Objective: To evaluate the effectiveness of corticosteroids with pirfenidone in patients of post-coronavirus disease-2019 pulmonary fibrosis in preventing long-term life-threatening sequelae. Method: The quasi-experimental study was conducted at the Department of Pharmacology, Army Medical College, Rawalpindi, and the Department of Pulmonology, Pakistan Emirates Military Hospital, Rawalpindi, Pakistan, from January to December 2024, and comprised patients with post- coronavirus disease-2019 pulmonary fibrosis who were divided into Group-A receiving corticosteroids and Group-B receiving a combination of pirfenidone and corticosteroids. Pulmonary fibrosis was diagnosed on the basis of high-resolution computed tomography findings. The participants were subjected to 6-minute walk test and pulse-oximetry, while Warrick scores for pulmonary fibrosis were also noted for each participant at 3 and 6 months. Data was analysed using SPSS 26. Results: Of the 40 patients, 20(50%) were in Group-A; 12(60%) males and 8 (40%) females with mean age 42.45±11.11 years. The other 20(50%) patients were in Group-B; 13(65%) males and 7(35%) females with mean age 43.15±8.64 years. Group-B showed higher improvement in 6-minute walk test compared to Group-A both at 90 days (p=0.189) and 180 days (p=0.002). Improvements in Oxygen saturation, Warrick score for fibrosis and fibrosis percentage were significantly higher in Group-B patients at 180-days follow-up as compared to Group-A (p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →